Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia

European Radiology

Volumn 23, Issue 4, 2013, Pages 951-957

  Chavan, Ajay ^a   Luthe, Lars ^a   Gebel, Michael ^b   Barg Hock, Hannelore ^b   Seifert, Hans ^a   Raab, Rudolph ^a   Kirchhoff, Timm ^b   Schmuck, B ^a  

^a KLINIKUM OLDENBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Arterio venous malformations; Biliary disease; Cardiac failure; Embolisation; Liver transplantation; Therapeutic

Indexed keywords

AMINOTRANSFERASE; ANALGESIC AGENT; POLYVINYL ALCOHOL;

ABDOMINAL ANGINA; ABDOMINAL PAIN; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CHOLANGITIS; CHOLECYSTITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSPNEA; ESOPHAGUS VARICES; FATIGUE; FEMALE; FOLLOW UP; FOOT EDEMA; HEART FAILURE; HEART OUTPUT; HEPATIC ARTERY; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HUMAN; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; MORTALITY; OUTCOME ASSESSMENT; PAIN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SEPSIS; WEIGHT REDUCTION;

EID: 84878538170     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2694-9     Document Type: Article

References (18)

1. Garcia-Tsao (2007) Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol 46:499-507
2. Buscarini E, Leandro G, Conte D, Danesino C, Daina E, Manfredi G et al. (2011) Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia. Dig Dis Sci 56:2166-2178
3. Buscarini E, Plauchu H, Garcia Tsao G et al. (2006) Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 26:1040-1046
4. Govani FS, Shovlin CL (2009) Hereditary hemorrhagic telangiectasia:a clinical and scientific review. Eur J Hum Genet 17:860-871
5. Faughnan ME, Palda VA, Garcia-Tsao G, et al. (2009) International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. J Med Genet. doi: 10.1136/jmg.2009.069013
6. Odorico JS, Hakim NM, Becker YT et al. (1998) Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transplant Surg 4:483-490
7. Whiting JH Jr, Korzenik JR, Miller FJ Jr et al. (2000) Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 11:855-858
8. Shovlin C, Guttmacher A, Buscarini E, Faughnan M, Hyland R, Westermann C et al. (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66-67
9. Chavan A, Galanski M, Wagner S, Caselitz M, Schlitt HJ, Gratz KF et al. (1998) Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations - Experience in five patients. Radiology 209:735-739
10. Chavan A, Caselitz M, Gratz K-F et al. (2004) Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Eur Radiol 14:2079-2085
11. Lerut J, Orlando G, Adam R et al. (2006) Liver transplantation for hereditary hemorrhagic telangiectasia. Report of the European liver transplant registry. Ann Surg 244:854-864
12. Azoulay D, Precetti S, Emile JF et al. (2002) Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience. Gastroenterol Clin Biol 26:828
13. Dupuis-Girod S, Chesnais A-L, Ginon I et al. (2010) Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Liver Transpl 16:340-347
14. Garcia-Tsao G, Korzenik JR, Young L et al. (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931-936
15. Pfitzmann R, Heise M, Langrehr JM et al. (2001) Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. Transplantation 72:237-241
16. Flieger D, Hainke S, Fischbach W (2006) Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann Hematol 85:631-632
17. Mitchell A, Adams LA, Macquillan G, Tibballs J, van den Driesen R, Delriviere L (2008) Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 14:210-213
18. Dupuis-Girod S, Ginon I, Saurin J-C et al. (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307:948-955